These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2692787)

  • 1. A balance between self-renewal and commitment in the murine erythroleukemia cells with the transferred c-myc gene; an in vitro stochastic model.
    Yamamoto T; Masuko K; Takada S; Kume TU; Obinata M
    Cell Differ Dev; 1989 Nov; 28(2):129-33. PubMed ID: 2692787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued withdrawal from the cell cycle and regulation of cellular genes in mouse erythroleukemia cells blocked in differentiation by the c-myc oncogene.
    Coppola JA; Parker JM; Schuler GD; Cole MD
    Mol Cell Biol; 1989 Apr; 9(4):1714-20. PubMed ID: 2657403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc interferes with the commitment to differentiation of murine erythroleukemia cells at a reversible point.
    Takada S; Yamamoto T; Ohmori Y; Matsui Y; Obinata M
    Jpn J Cancer Res; 1992 Jan; 83(1):61-5. PubMed ID: 1544874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
    Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation-dependent repression of c-myc, B22, COX II and COX IV genes in murine erythroleukemia (MEL) cells.
    Vizirianakis IS; Pappas IS; Tsiftsoglou AS
    Biochem Pharmacol; 2002 Mar; 63(5):1009-17. PubMed ID: 11911854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probability that the commitment of murine erythroleukemia cell differentiation is determined by the c-myc level.
    Kume TU; Takada S; Obinata M
    J Mol Biol; 1988 Aug; 202(4):779-86. PubMed ID: 3172238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Prochownik EV; Kukowska J
    Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells.
    Spotts GD; Hann SR
    Mol Cell Biol; 1990 Aug; 10(8):3952-64. PubMed ID: 2196440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myb but not c-myc suppresses the hemin-induced nonterminal expression of hemoglobin by murine erythroleukemia cells.
    Prochownik EV
    Blood; 1989 Feb; 73(3):782-6. PubMed ID: 2644989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-induction of c-fos and junB during the latent period preceding commitment of Friend erythroleukemia cells to differentiation.
    Francastel C; Mazouzi Z; Robert-Lézénès J
    Leukemia; 1992 Sep; 6(9):935-9. PubMed ID: 1518304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
    Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection of mouse erythroleukemia cells with myc sequences changes the rate of induced commitment to differentiate.
    Lachman HM; Cheng GH; Skoultchi AI
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6480-4. PubMed ID: 3529085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
    Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
    J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of c-myc and bcl-2 gene expression in PU.1-induced apoptosis in murine erythroleukemia cells.
    Kihara-Negishi F; Yamada T; Kubota Y; Kondoh N; Yamamoto H; Abe M; Shirai T; Hashimoto Y; Oikawa T
    Int J Cancer; 1998 May; 76(4):523-30. PubMed ID: 9590129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium ionophore-induced transient down-regulation of c-myb mRNA levels in Friend erythroleukemia cells.
    Schaefer A; Stöcker U; Marquardt H
    J Biol Chem; 1993 May; 268(15):10876-80. PubMed ID: 8496152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of c-myc transcript in differentiation-defective mouse erythroleukemia cells.
    Sasaki H; Watanabe T; Nomura S; Oishi M
    Jpn J Cancer Res; 1987 Aug; 78(8):776-9. PubMed ID: 3115922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters.
    Kohlhuber F; Strobl LJ; Eick D
    Oncogene; 1993 Apr; 8(4):1099-102. PubMed ID: 8455938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-myb effects on kinetic events during MEL cell differentiation.
    Danish R; el-Awar O; Weber BL; Langmore J; Turka LA; Ryan JJ; Clarke MF
    Oncogene; 1992 May; 7(5):901-7. PubMed ID: 1533276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.